Literature DB >> 31077666

Racial, Ethnic, and Socioeconomic Disparities in Retinoblastoma Enucleation: A Population-Based Study, SEER 18 2000-2014.

Nitya Rajeshuni1, Alice S Whittemore2, Cassie A Ludwig3, Prithvi Mruthyunjaya3, Darius M Moshfeghi4.   

Abstract

PURPOSE: To determine the effect of race, ethnicity, and census tract-level composite socioeconomic status (SES) on retinoblastoma enucleation. This study augments Truong and associates, providing multivariate analyses combining sociodemographic and clinical characteristics with more accurate SES measures. We hypothesized that children from nonwhite, Hispanic, and lower socioeconomic backgrounds would have increased adjusted odds of enucleation.
DESIGN: Retrospective cohort analysis.
SETTING: Multicenter population-based study using the Surveillance, Epidemiology, and End Results (SEER) 18 Registries. STUDY POPULATION: Children aged 18 years and younger diagnosed with retinoblastoma between 2000 and 2014. Subjects were identified using International Classification of Diseases-Oncology (ICD-O) site and morphology codes. MAIN OUTCOME MEASURES: Enucleation odds ratios (ORs) and 95% confidence intervals (CIs).
RESULTS: Analysis of 959 retinoblastoma patients revealed that 70.8% were enucleated. Adjusted analyses showed associations between enucleation and Asian (OR 2.00, CI 1.08-3.71) or black (2.42, 1.41-4.16) race, Hispanic ethnicity (1.69, 1.16-2.46), and low SES (1.68, 1.09-2.58). Significantly increased enucleation risk was associated with older age at diagnosis (age 1-2 years 2.55, 1.80-3.61; >2 years 4.88, 2.57-9.25), unilateral disease (5.00, 3.45-7.14), and advanced stage (regional 4.71, 2.51-8.84; distant 3.15, 1.63-6.08). No interactions were observed between race, ethnicity, SES, and stage at diagnosis. Enucleation rates decreased over time across all racial, ethnic, and socioeconomic groups.
CONCLUSIONS: Children from nonwhite, Hispanic, and lower socioeconomic backgrounds are more likely to receive enucleation. These associations are independent of stage of diagnosis, suggesting larger systemic disparities in retinoblastoma care. The origin of these differences requires further study and attention by clinicians and policy makers.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 31077666     DOI: 10.1016/j.ajo.2019.04.015

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  5 in total

1.  Long non-coding RNA UCA1 promotes retinoblastoma progression by modulating the miR-124/c-myc axis.

Authors:  Lan Wang; Mingxing Wu; Xiyuan Zhou
Journal:  Am J Transl Res       Date:  2022-03-15       Impact factor: 4.060

2.  Evaluation of Racial, Ethnic, and Socioeconomic Associations With Treatment and Survival in Uveal Melanoma, 2004-2014.

Authors:  Nitya Rajeshuni; Talhah Zubair; Cassie A Ludwig; Darius M Moshfeghi; Prithvi Mruthyunjaya
Journal:  JAMA Ophthalmol       Date:  2020-08-01       Impact factor: 7.389

3.  Role of ethnicity and socioeconomic status (SES) in the presentation of retinoblastoma: findings from the UK.

Authors:  Rabia Bourkiza; Phillippa Cumberland; Ido Didi Fabian; Hiranya Abeysekera; Manoj Parulekar; Mandeep S Sagoo; Jugnoo Rahi; M Ashwin Reddy
Journal:  BMJ Open Ophthalmol       Date:  2020-05-15

4.  Dinutuximab Synergistically Enhances the Cytotoxicity of Natural Killer Cells to Retinoblastoma Through the Perforin-Granzyme B Pathway.

Authors:  Huixue Wang; Jie Yang; Hui Pan; Mei Chee Tai; Mohamed H Maher; Renbing Jia; Shengfang Ge; Linna Lu
Journal:  Onco Targets Ther       Date:  2020-05-08       Impact factor: 4.147

Review 5.  New insights into the prognosis of intraocular malignancy: Interventions for association mechanisms between cancer and diabetes.

Authors:  Lingwen Gu; Guofeng Ma; Cui Li; Jing Lin; Guiqiu Zhao
Journal:  Front Oncol       Date:  2022-08-08       Impact factor: 5.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.